Report overview
Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
This report aims to provide a comprehensive presentation of the global market for Cancer Pain Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Pain Therapeutics. This report contains market size and forecasts of Cancer Pain Therapeutics in global, including the following market information:
Global Cancer Pain Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Cancer Pain Therapeutics Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Cancer Pain Therapeutics companies in 2022 (%)
The global Cancer Pain Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Pain Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Pain Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Pain Therapeutics Market Segment Percentages, by Type, 2022 (%)
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Global Cancer Pain Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Pain Therapeutics Market Segment Percentages, by Application, 2022 (%)
Paracetamol Treatment-Related Immunotherapy
Radiotherapy
Chemotherapy
Hormone Therapy
Global Cancer Pain Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Cancer Pain Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Pain Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Pain Therapeutics revenues share in global market, 2022 (%)
Key companies Cancer Pain Therapeutics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Pain Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson?Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Pain Therapeutics, market overview.
Chapter 2: Global Cancer Pain Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Pain Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Pain Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Pain Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
